2Biological aspects of multiple myeloma
- 1 December 1995
- journal article
- Published by Elsevier in Bailliere's Clinical Haematology
- Vol. 8 (4) , 721-734
- https://doi.org/10.1016/s0950-3536(05)80256-2
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain [published erratum appears in Blood 1995 Jun 1;85(11):3365]Blood, 1995
- High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myelomaBlood, 1994
- The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.The Journal of Experimental Medicine, 1993
- Functional expression of B7/BB1 on activated T lymphocytes.The Journal of Experimental Medicine, 1993
- Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma.Journal of Clinical Investigation, 1991
- Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma.The Journal of Experimental Medicine, 1989
- Plasma cell myeloma--new biological insights and advances in therapyBlood, 1989
- Decrease in BSF-2/IL-6 response in advanced cases of multiple myelomaBlood, 1988
- Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myelomaBlood, 1987
- Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas.Molecular and Cellular Biology, 1986